Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to $1.4 million.

  • Fennec Pharmaceuticals' Prepaid Assets fell 5437.05% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 5437.05%. This contributed to the annual value of $3.1 million for FY2024, which is 1961.17% up from last year.
  • According to the latest figures from Q3 2025, Fennec Pharmaceuticals' Prepaid Assets is $1.4 million, which was down 5437.05% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Prepaid Assets ranged from a high of $4.5 million in Q1 2024 and a low of $278000.0 during Q3 2022
  • Its 5-year average for Prepaid Assets is $1.6 million, with a median of $1.2 million in 2021.
  • Per our database at Business Quant, Fennec Pharmaceuticals' Prepaid Assets tumbled by 7743.51% in 2022 and then surged by 85820.57% in 2024.
  • Over the past 5 years, Fennec Pharmaceuticals' Prepaid Assets (Quarter) stood at $1.2 million in 2021, then plummeted by 37.5% to $770000.0 in 2022, then soared by 234.42% to $2.6 million in 2023, then increased by 19.61% to $3.1 million in 2024, then plummeted by 54.58% to $1.4 million in 2025.
  • Its Prepaid Assets was $1.4 million in Q3 2025, compared to $1.4 million in Q2 2025 and $2.4 million in Q1 2025.